IST:BIOEN Statistics

Total Valuation

IST:BIOEN has a market cap or net worth of TRY 9.53 billion. The enterprise value is 13.39 billion.

Market Cap	9.53B
Enterprise Value	13.39B

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

IST:BIOEN has 500.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	500.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-2.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	20.49%
Float	227.51M

Valuation Ratios

The trailing PE ratio is 96.61.

PE Ratio	96.61
Forward PE	n/a
PS Ratio	3.54
PB Ratio	2.38
P/TBV Ratio	2.69
P/FCF Ratio	15.08
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 54.17, with an EV/FCF ratio of 21.19.

EV / Earnings	135.80
EV / Sales	4.98
EV / EBITDA	54.17
EV / EBIT	n/a
EV / FCF	21.19

Financial Position

The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.99.

Current Ratio	0.64
Quick Ratio	0.20
Debt / Equity	0.99
Debt / EBITDA	11.24
Debt / FCF	6.26
Interest Coverage	-0.80

Financial Efficiency

Return on equity (ROE) is 2.43% and return on invested capital (ROIC) is -2.77%.

Return on Equity (ROE)	2.43%
Return on Assets (ROA)	-2.52%
Return on Invested Capital (ROIC)	-2.77%
Return on Capital Employed (ROCE)	-5.36%
Revenue Per Employee	3.75M
Profits Per Employee	137,511
Employee Count	717
Asset Turnover	0.30
Inventory Turnover	6.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.32% in the last 52 weeks. The beta is -0.01, so IST:BIOEN's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	+11.32%
50-Day Moving Average	16.50
200-Day Moving Average	17.81
Relative Strength Index (RSI)	60.12
Average Volume (20 Days)	5,122,473

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:BIOEN had revenue of TRY 2.69 billion and earned 98.60 million in profits. Earnings per share was 0.20.

Revenue	2.69B
Gross Profit	118.92M
Operating Income	-367.39M
Pretax Income	137.29M
Net Income	98.60M
EBITDA	251.77M
EBIT	-367.39M
Earnings Per Share (EPS)	0.20

Full Income Statement

Balance Sheet

The company has 98.57 million in cash and 3.95 billion in debt, giving a net cash position of -3.85 billion or -7.71 per share.

Cash & Cash Equivalents	98.57M
Total Debt	3.95B
Net Cash	-3.85B
Net Cash Per Share	-7.71
Equity (Book Value)	4.01B
Book Value Per Share	8.00
Working Capital	-631.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.32 billion and capital expenditures -692.24 million, giving a free cash flow of 631.73 million.

Operating Cash Flow	1.32B
Capital Expenditures	-692.24M
Free Cash Flow	631.73M
FCF Per Share	1.26

Full Cash Flow Statement

Margins

Gross margin is 4.42%, with operating and profit margins of -13.67% and 3.67%.

Gross Margin	4.42%
Operating Margin	-13.67%
Pretax Margin	5.11%
Profit Margin	3.67%
EBITDA Margin	9.37%
EBIT Margin	-13.67%
FCF Margin	23.50%

Dividends & Yields

IST:BIOEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.04%
FCF Yield	6.63%

Stock Splits

The last stock split was on November 24, 2021. It was a forward split with a ratio of 3.3333333.

Last Split Date	Nov 24, 2021
Split Type	Forward
Split Ratio	3.3333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a